Similar articles

• Reversible monoamine-A inhibitors in panic disorder.

  Bakish D. Bakish D. Clin Neuropharmacol. 1992;15 Suppl 1 Pt A:432A-433A. doi: 10.1097/00002826-199201001-00226. Clin Neuropharmacol. 1992. PMID: 1498904 No abstract available.
• [Panic disorder and agoraphobia].

  Koga M. Koga M. Ryoikibetsu Shokogun Shirizu. 2003;(38):418-21. Ryoikibetsu Shokogun Shirizu. 2003. PMID: 12877016 Review. Japanese. No abstract available.
• Are benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia?

  Bruce SE, Vasile RG, Goisman RM, Salzman C, Spencer M, Machan JT, Keller MB. Bruce SE, et al. Am J Psychiatry. 2003 Aug;160(8):1432-8. doi: 10.1176/appi.ajp.160.8.1432. Am J Psychiatry. 2003. PMID: 12900305
• What treatments do patients with panic disorder and agoraphobia get?

  Bandelow B, Sievert K, Röthemeyer M, Hajak G, Rüther E. Bandelow B, et al. Eur Arch Psychiatry Clin Neurosci. 1995;245(3):165-71. doi: 10.1007/BF02193090. Eur Arch Psychiatry Clin Neurosci. 1995. PMID: 7669824
• Treatment strategies of obsessive-compulsive disorder and panic disorder/agoraphobia.

  Marazziti D, Carlini M, Dell'Osso L. Marazziti D, et al. Curr Top Med Chem. 2012;12(4):238-53. doi: 10.2174/1568026799078688. Curr Top Med Chem. 2012. PMID: 22204483 Review.